Indication
Diarrhea related to cancer therapy
1 clinical trial
2 products
Product
CrofelemerClinical trial
A Phase 3 Multicenter, Randomized, Double-blind Placebo-controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients With Solid Tumors Receiving Targeted-cancer Therapies With or Without Standard ChemotherapyStatus: Active (not recruiting), Estimated PCD: 2024-04-01
Product
Placebo